EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Reverse Remodelling, Myocardial Recovery and Remission in Heart Failure with Reduced Ejection Fraction: Clinical Implications and Management Strategies

Silas Ramos Furquim iD, Maria Tereza Sampaio de Sousa Lira iD, Deborah de Sá Pereira Belfort iD, Bruno Biselli iD, Paulo Roberto Chizzola iD, Robinson Tadeu Munhoz iD, Edimar Alcides Bocchi iD, Silvia Moreira Ayub-Ferreira iD

Cardiac Failure Review · 15.12.2025

DOI: 10.15420/cfr.2025.41 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiac Failure Review, online erschienen am 15.12.2025. Verfasst von Silas Ramos Furquim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo São Paulo, Brazil. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac reverse remodelling (RR) is a complex process involving structural and functional recovery of the myocardium, with significant implications for the prognosis of patients with heart failure (HF). This review summarises current concepts, underlying mechanisms, therapeutic strategies, and clinical implications of RR, while distinguishing it from myocardial recovery and remission. Both pharmacological therapies and non-pharmacological interventions have shown potential to induce RR in selected populations. Clinical features, echocardiographic parameters, advanced imaging findings, and biomarkers help stratify patients according to the likelihood of recovery and risk of relapse. The management of HF with improved ejection fraction remains debated. High recurrence rates are seen after therapy discontinuation; however, evidence suggests that partial withdrawal may be safe in specific patient profiles. RR should be considered a central therapeutic goal in HF care, although its extent and stability vary widely. Differentiating between transient improvement, remission under therapy, and true myocardial recovery is critical for guiding long-term treatment decisions, highlighting the importance of individualised follow-up.

Schlagwörter

Stichwörter der Autor:innen

Reverse remodellingheart failureimproved ejection fractionmyocardial recoverypharmacological therapyprognosis

Autor:innen und Institutionen

  • Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo São Paulo, Brazil.

ORCID-Profile: Silas Ramos Furquim, Maria Tereza Sampaio de Sousa Lira, Deborah de Sá Pereira Belfort, Bruno Biselli, Paulo Roberto Chizzola, Robinson Tadeu Munhoz, Edimar Alcides Bocchi, Silvia Moreira Ayub-Ferreira

Zitieren

APA

Furquim, S. R., Lira, M. T. S. S., Belfort, D. S. P., Biselli, B., Chizzola, P. R., Munhoz, R. T., Bocchi, E. A., & Ayub-Ferreira, S. M. (2025). Reverse Remodelling, Myocardial Recovery and Remission in Heart Failure with Reduced Ejection Fraction: Clinical Implications and Management Strategies. Cardiac Failure Review. https://doi.org/10.15420/cfr.2025.41

Vancouver

Furquim SR, Lira MTSS, Belfort DSP, Biselli B, Chizzola PR, Munhoz RT, et al. Reverse Remodelling, Myocardial Recovery and Remission in Heart Failure with Reduced Ejection Fraction: Clinical Implications and Management Strategies. Cardiac Failure Review. 2025. doi:10.15420/cfr.2025.41

BibTeX
@article{Furquim2025,
  author = {Furquim, Silas Ramos and Lira, Maria Tereza Sampaio de Sousa and Belfort, Deborah de Sá Pereira and Biselli, Bruno and Chizzola, Paulo Roberto and Munhoz, Robinson Tadeu and Bocchi, Edimar Alcides and Ayub-Ferreira, Silvia Moreira},
  title = {Reverse Remodelling, Myocardial Recovery and Remission in Heart Failure with Reduced Ejection Fraction: Clinical Implications and Management Strategies},
  journal = {Cardiac Failure Review},
  year = {2025},
  doi = {10.15420/cfr.2025.41}
}
Kostenlos starten →